Literature DB >> 18617440

Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.

Kay D Brantsch1, Christoph Meisner, Birgitt Schönfisch, Birgit Trilling, Jörg Wehner-Caroli, Martin Röcken, Helmut Breuninger.   

Abstract

BACKGROUND: Cutaneous squamous-cell carcinomas (SCC) are among the most common cancers capable of metastasis. Current Tumour Node Metastasis (TNM) staging includes horizontal tumour size, involvement of extradermal structures, and degree of differentiation. The aim of this study was to prospectively analyse the key factors predicting metastasis and local recurrence in cutaneous SCC.
METHODS: We assessed prospectively investigated potential risk factors for metastasis or local recurrence of SCC, previously suggested by retrospective studies and small case series, in 615 white patients. Between Jan 1, 1990, and Dec 31, 2001, all patients underwent surgery for cutaneous SCC with complete histological examination of the three-dimensional excision margins (3D-histology) in one centre. Univariate and multivariate analysis included tumour thickness, horizontal size, body site, histological differentiation, desmoplastic growth, history of multiple SCC, and immunosuppression. Primary endpoints were time to metastasis and time to local recurrence, defined as the time from date of diagnosis of the primary tumour to the date of diagnosis of metastasis or local recurrence, respectively.
FINDINGS: 653 patients were enrolled in the study. 38 patients were lost to follow-up leaving 615 assessable patients (median age 73 years [range 27-98]). During a median follow-up period of 43 months (range 1-165), 26 (4%) of 615 patients developed metastases and 20 patients developed local recurrence (3%). Tumours 2.0 mm or less in thickness did not metastasise. Metastases occurred in 12 (4%) of 318 tumours between 2.1 mm and 6.0 mm in thickness, and in 14 (16%) of 90 tumours with a thickness greater than 6.0 mm. On multivariate analysis, key prognostic factors for metastasis were increased tumour thickness (hazard ratio 4.79 [95% CI 2.22-10.36]; p<0.0001), immunosuppression (4.32 [1.62-11.52]; p=0.0035), localisation at the ear (3.61 [1.51-8.67]; p=0.0040), and increased horizontal size (2.22 [1.18-4.15]; p=0.0128). The risk of local recurrence depended on increased tumour thickness (6.03 [2.71-13.43]; p<0.0001) and desmoplasia (16.11 [6.57-39.49]; p<0.0001).
INTERPRETATION: Only SCC greater than 2.0 mm in thickness are associated with a significant risk of metastasis. Tumours greater than 6.0 mm are associated with a high risk of metastasis and local recurrence. Desmoplastic growth is an independent risk factor for local recurrence. Studies should assess the role of follow-up visits and sentinel-lymph-node biopsy in high-risk patients.

Entities:  

Mesh:

Year:  2008        PMID: 18617440     DOI: 10.1016/S1470-2045(08)70178-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  170 in total

1.  Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.

Authors:  Joana Lanz; Jan Nico Bouwes Bavinck; Marlies Westhuis; Koen D Quint; Catherine A Harwood; Shaaira Nasir; Vanessa Van-de-Velde; Charlotte M Proby; Carlos Ferrándiz; Roel E Genders; Véronique Del Marmol; Giulia Forchetti; Jürg Hafner; Domenic G Vital; Guenther F L Hofbauer
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Management of high-risk cutaneous squamous cell carcinoma.

Authors:  Lorraine Jennings; Chrysalyne D Schmults
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

3.  Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.

Authors:  Emily Stamell Ruiz; Pritesh S Karia; Robert Besaw; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

4.  The role of elective superficial parotidectomy in the treatment of temporal region squamous cell carcinoma.

Authors:  Sameep Kadakia; Yadranko Ducic; Diego Marra; Masoud Saman
Journal:  Oral Maxillofac Surg       Date:  2015-12-21

5.  The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.

Authors:  Christopher Metchnikoff; Thaddeus Mully; Jonathan P Singer; Jeffrey A Golden; Sarah T Arron
Journal:  J Am Acad Dermatol       Date:  2012-01-29       Impact factor: 11.527

Review 6.  [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].

Authors:  M Majores; E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 7.  Cutaneous squamous cell carcinoma in the organ transplant recipient.

Authors:  Kristin Bibee; Andrew Swartz; Shaum Sridharan; Cornelius H L Kurten; Charles B Wessel; Heath Skinner; Dan P Zandberg
Journal:  Oral Oncol       Date:  2020-02-14       Impact factor: 5.337

8.  Hedgehog/Gli1 signal pathway facilitates proliferation, invasion, and migration of cutaneous SCC through regulating VEGF.

Authors:  Qian Sun; Jing Bai; Renrong Lv
Journal:  Tumour Biol       Date:  2016-10-17

9.  MicroRNA expression profiling in metastatic cutaneous squamous cell carcinoma.

Authors:  J Gillespie; L E Skeeles; D C Allain; M N Kent; S B Peters; P Nagarajan; L Yu; T N Teknos; T Olencki; A E Toland
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-03-12       Impact factor: 6.166

10.  Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.

Authors:  Zoë C Venables; Philippe Autier; Tamar Nijsten; Kwok F Wong; Sinéad M Langan; Brian Rous; John Broggio; Catherine Harwood; Katherine Henson; Charlotte M Proby; Jem Rashbass; Irene M Leigh
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.